Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

<p><strong>Background:</strong> Molnupiravir and nirmatrelvir-ritonavir (Paxlovid) are oral antivirals that have been proposed as treatments for patients admitted to hospital with COVID-19.</p> <br> <p><strong>Methods:</strong> In this randomised, cont...

Full description

Bibliographic Details
Main Authors: RECOVERY Collaborative Group, Horby, PW, Staplin, N, Peto, L, Emberson, JR, Campbell, M, Pessoa-Amorim, G, Basnyat, B, Thwaites, L, Van Doorn, R, Hamers, RL, Nel, J, Amuasi, J, Stewart, R, Ghosh, D, Hamilton, F, Desai, P, Easom, N, Majumdar, J, Hine, P, Chadwick, D, Cooke, G, Sharp, S, Esmail, H, Baillie, JK, Buch, MH, Faust, SN, Jaki, T, Jeffery, K, Juszczak, E, Knight, M, Lim, WS, Montgomery, A, Mukherjee, A, Mumford, A, Rowan, K, Thwaites, G, Mafham, M, Haynes, R, Landray, MJ
Format: Internet publication
Language:English
Published: 2024

Similar Items